The main idea here is that insulin pump therapy still requires vigilance and ongoing management because insulin delivery can be interrupted. Even with a pump, you can develop insulin deficiency if the pump stops delivering insulin due to a failed infusion, empty reservoir, kinked tubing, or site issue. When delivery stops, blood glucose can rise quickly and progress to diabetic ketoacidosis if not recognized and treated promptly. So saying you don’t have to worry about insulin reactions or ketoacidosis again is a misconception that needs targeted teaching: you still monitor blood glucose, check for ketones if glucose is high, have a plan for pump problems, and know when to switch to alternative insulin delivery if needed. In practice, you should continue checking blood sugars before meals to determine whether a bolus is needed, you can administer correction boluses for elevated readings, and you still follow a diet and exercise plan. These steps reflect ongoing, proactive management that remains essential with pump therapy.

Distinguishing CSF drainage from nasal mucus after transsphenoidal hypophysectomy relies on a characteristic chemical difference: CSF contains glucose, while nasal mucus does not in a reliable way. CSF glucose is typically about 60% of the plasma glucose level, so a drainage sample that shows measurable glucose strongly suggests CSF. A quick bedside glucose test on the drainage therefore provides a direct, practical way to confirm a CSF leak versus mucus. Lowering the head of the bed is a management step to reduce pressure and potential leaking but does not tell you whether the drainage is CSF or mucus. Culturing the drainage would look for infection, not differentiate CSF from mucus. Simply observing the drainage over time does not provide the diagnostic distinction needed.

In thyroid storm you want rapid control of hormone levels by first stopping new hormone production, then quickly blocking release of what’s already stored, while supporting peripheral effects. Propylthiouracil (PTU) does the crucial job of inhibiting thyroid hormone synthesis (and also decreases T4 to T3 conversion). Once synthesis is being blocked, giving iodide can promptly shut down the release of stored thyroid hormone. Because iodide can, in the absence of synthesis blockade, potentially sustain or increase hormone production in some scenarios, it’s given after PTU so that synthesis is already suppressed when iodide acts. Adding steroids helps reduce peripheral conversion of T4 to T3 and treats potential adrenal insufficiency, providing broad stabilization. So the preferred sequence is PTU first, followed by iodide, with steroids.

The key idea is whether puberty is driven by the hypothalamic-pituitary-gonadal axis or by outside sources of sex steroids. In central precocious puberty, the axis is activated early, so the pituitary readily responds to GnRH with an increase in LH and FSH, driving higher sex steroid levels. A GnRH stimulation test in this scenario shows a rise in both LH and FSH, reflecting gonadotropin dependence. In peripheral precocious puberty, sex steroids come from the ovaries, adrenals, or exogenous sources, independent of the pituitary. The high sex steroids suppress pituitary gonadotropin production via negative feedback, so basal LH and FSH are low and show little or no increase with GnRH stimulation, even though sex steroids are elevated. So the best description is that central precocious puberty has an elevated LH/FSH response to GnRH, while peripheral precocious puberty has suppressed gonadotropins with elevated sex steroids.